Acta Marisiensis.
|
|
||||||
Year 2024
Volume 21 (XXXVIII), no 1 Volume 21 (XXXVIII), no 2 Year 2023 Volume 20 (XXXVII), no 1 Volume 20 (XXXVII), no 2 Year 2022 Volume 19 (XXXVI), no 1 Volume 19 (XXXVI), no 2 Year 2021 Volume 18 (XXXV), no 1 Volume 18 (XXXV), no 2 Year 2020 Volume 17 (XXXIV), no 1 Volume 17 (XXXIV), no 2 Year 2019 Volume 16 (XXXIII), no 1 Volume 16 (XXXIII), no 2 Year 2018 Volume 15 (XXXII), no 1 Volume 15 (XXXII), no 2 Year 2017 Volume 14 (XXXI), no 1 Volume 14 (XXXI), no 2 Year 2016 Volume 13 (XXX), no 1 Volume 13 (XXX), no 2 Year 2015 Volume 12 (XXIX), no 1 Volume 12 (XXIX), no 2 Year 2014 Volume 11 (XXVIII), no 1 Volume 11 (XXVIII), no 2 Year 2013 Volume 10 (XXVII), no 1 Volume 10 (XXVII), no 2 Year 2012 Volume 9 (XXVI), no 1 Volume 9 (XXVI), no 2 Year 2011 Volume 8 (XXV), no 1 Volume 8 (XXV), no 2 Year 2010 Volume 7 (XXIV), no 1 Volume 7 (XXIV), no 2 Year 2009 Volume 6 (XXIII) |
2024, Volume 21 (XXXVIII), no 2
Vlad-Alexandru ANITEI, Albert-Zsolt BARABAS, University of Medicine, Pharmacy, Science and Technology ”G.E. Palade” of Târgu Mureș, Romania Abstract: The NoBoCap training program for market operators has played a critical role in supporting the implementation of the European Union's Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). This initiative seeks to equip market operators with the essential knowledge and skills required to navigate the rigorous compliance requirements of these regulations. The present study aimed to assess the program’s effectiveness by focusing on three core objectives: (1) evaluating participant needs, (2) analyzing the efficacy of marketing strategies, and (3) measuring course outcomes. A mixed-methods approach was employed, incorporating participant feedback, marketing campaign analytics, and needs assessment surveys. The findings demonstrated a significant improvement in participant understanding of regulatory requirements, supported by robust marketing strategies that effectively engaged the target audience. Notably, the study identified regional variations in training success rates, underscoring the importance of localized marketing efforts and customized training content. These insights highlight the critical need for ongoing professional development programs tailored to the evolving regulatory landscape. Implications of the findings suggest that future regulatory training initiatives should prioritize data-driven decision-making and iterative improvements in program design to maximize impact. This study reinforces the importance of targeted training strategies in enhancing regulatory compliance within the medical device and diagnostics sectors. DOI: https://doi.org/10.62838/amset-2024-0012 Pages: 15-19 View full article |
||||||
Update: 18-Dec-2024 | © Published by University Press |